Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005777 | peroxisome | 6 | 1 |
GO:0020015 | glycosome | 7 | 1 |
GO:0042579 | microbody | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0005789 | endoplasmic reticulum membrane | 4 | 1 |
GO:0031090 | organelle membrane | 3 | 1 |
Related structures:
AlphaFold database: A4HEG5
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:0000038 | very long-chain fatty acid metabolic process | 5 | 1 |
GO:0006082 | organic acid metabolic process | 3 | 1 |
GO:0006631 | fatty acid metabolic process | 4 | 1 |
GO:0006633 | fatty acid biosynthetic process | 5 | 1 |
GO:0008610 | lipid biosynthetic process | 4 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016053 | organic acid biosynthetic process | 4 | 1 |
GO:0019752 | carboxylic acid metabolic process | 5 | 1 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 1 |
GO:0042761 | very long-chain fatty acid biosynthetic process | 6 | 1 |
GO:0043436 | oxoacid metabolic process | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044255 | cellular lipid metabolic process | 3 | 1 |
GO:0044281 | small molecule metabolic process | 2 | 1 |
GO:0044283 | small molecule biosynthetic process | 3 | 1 |
GO:0046394 | carboxylic acid biosynthetic process | 5 | 1 |
GO:0072330 | monocarboxylic acid biosynthetic process | 6 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity | 5 | 5 |
GO:0016229 | steroid dehydrogenase activity | 3 | 5 |
GO:0016491 | oxidoreductase activity | 2 | 11 |
GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors | 3 | 11 |
GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors | 4 | 5 |
GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 4 | 1 |
GO:0102758 | very-long-chain enoyl-CoA reductase activity | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 7 | 11 | PF00656 | 0.633 |
CLV_NRD_NRD_1 | 12 | 14 | PF00675 | 0.449 |
CLV_NRD_NRD_1 | 225 | 227 | PF00675 | 0.431 |
CLV_NRD_NRD_1 | 39 | 41 | PF00675 | 0.278 |
CLV_PCSK_KEX2_1 | 149 | 151 | PF00082 | 0.233 |
CLV_PCSK_PC1ET2_1 | 149 | 151 | PF00082 | 0.233 |
CLV_PCSK_SKI1_1 | 168 | 172 | PF00082 | 0.261 |
CLV_PCSK_SKI1_1 | 41 | 45 | PF00082 | 0.265 |
CLV_PCSK_SKI1_1 | 99 | 103 | PF00082 | 0.214 |
DEG_APCC_DBOX_1 | 63 | 71 | PF00400 | 0.627 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.485 |
DOC_MAPK_gen_1 | 13 | 19 | PF00069 | 0.576 |
DOC_MAPK_gen_1 | 149 | 157 | PF00069 | 0.477 |
DOC_MAPK_gen_1 | 29 | 38 | PF00069 | 0.440 |
DOC_MAPK_gen_1 | 299 | 307 | PF00069 | 0.424 |
DOC_MAPK_gen_1 | 62 | 70 | PF00069 | 0.601 |
DOC_MAPK_MEF2A_6 | 137 | 144 | PF00069 | 0.382 |
DOC_MAPK_NFAT4_5 | 137 | 145 | PF00069 | 0.382 |
DOC_PP4_FxxP_1 | 160 | 163 | PF00568 | 0.492 |
DOC_PP4_FxxP_1 | 43 | 46 | PF00568 | 0.527 |
DOC_USP7_MATH_1 | 198 | 202 | PF00917 | 0.222 |
DOC_USP7_MATH_1 | 243 | 247 | PF00917 | 0.309 |
DOC_USP7_MATH_1 | 31 | 35 | PF00917 | 0.530 |
DOC_USP7_MATH_1 | 51 | 55 | PF00917 | 0.622 |
DOC_WW_Pin1_4 | 187 | 192 | PF00397 | 0.373 |
LIG_14-3-3_CanoR_1 | 40 | 44 | PF00244 | 0.479 |
LIG_BRCT_BRCA1_1 | 189 | 193 | PF00533 | 0.301 |
LIG_BRCT_BRCA1_1 | 267 | 271 | PF00533 | 0.251 |
LIG_FHA_1 | 133 | 139 | PF00498 | 0.268 |
LIG_FHA_1 | 143 | 149 | PF00498 | 0.296 |
LIG_FHA_1 | 231 | 237 | PF00498 | 0.226 |
LIG_FHA_1 | 262 | 268 | PF00498 | 0.291 |
LIG_FHA_2 | 22 | 28 | PF00498 | 0.490 |
LIG_FHA_2 | 67 | 73 | PF00498 | 0.560 |
LIG_FHA_2 | 86 | 92 | PF00498 | 0.400 |
LIG_GBD_Chelix_1 | 110 | 118 | PF00786 | 0.382 |
LIG_LIR_Apic_2 | 105 | 109 | PF02991 | 0.249 |
LIG_LIR_Apic_2 | 42 | 46 | PF02991 | 0.523 |
LIG_LIR_Gen_1 | 179 | 188 | PF02991 | 0.313 |
LIG_LIR_Gen_1 | 256 | 262 | PF02991 | 0.262 |
LIG_LIR_Nem_3 | 100 | 106 | PF02991 | 0.465 |
LIG_LIR_Nem_3 | 179 | 183 | PF02991 | 0.343 |
LIG_LIR_Nem_3 | 201 | 206 | PF02991 | 0.261 |
LIG_LIR_Nem_3 | 256 | 260 | PF02991 | 0.262 |
LIG_LIR_Nem_3 | 268 | 274 | PF02991 | 0.289 |
LIG_LIR_Nem_3 | 88 | 92 | PF02991 | 0.464 |
LIG_MLH1_MIPbox_1 | 189 | 193 | PF16413 | 0.215 |
LIG_MLH1_MIPbox_1 | 268 | 272 | PF16413 | 0.349 |
LIG_PALB2_WD40_1 | 266 | 274 | PF16756 | 0.248 |
LIG_PCNA_yPIPBox_3 | 234 | 245 | PF02747 | 0.303 |
LIG_Pex14_2 | 143 | 147 | PF04695 | 0.325 |
LIG_Pex14_2 | 156 | 160 | PF04695 | 0.501 |
LIG_Pex14_2 | 203 | 207 | PF04695 | 0.206 |
LIG_PTB_Apo_2 | 170 | 177 | PF02174 | 0.414 |
LIG_PTB_Phospho_1 | 170 | 176 | PF10480 | 0.414 |
LIG_SH2_CRK | 106 | 110 | PF00017 | 0.249 |
LIG_SH2_CRK | 98 | 102 | PF00017 | 0.455 |
LIG_SH2_PTP2 | 139 | 142 | PF00017 | 0.327 |
LIG_SH2_STAP1 | 134 | 138 | PF00017 | 0.268 |
LIG_SH2_STAT5 | 103 | 106 | PF00017 | 0.314 |
LIG_SH2_STAT5 | 134 | 137 | PF00017 | 0.275 |
LIG_SH2_STAT5 | 139 | 142 | PF00017 | 0.263 |
LIG_SH2_STAT5 | 186 | 189 | PF00017 | 0.261 |
LIG_SH2_STAT5 | 250 | 253 | PF00017 | 0.214 |
LIG_SH2_STAT5 | 291 | 294 | PF00017 | 0.428 |
LIG_SH3_1 | 234 | 240 | PF00018 | 0.245 |
LIG_SH3_2 | 163 | 168 | PF14604 | 0.445 |
LIG_SH3_3 | 160 | 166 | PF00018 | 0.479 |
LIG_SH3_3 | 234 | 240 | PF00018 | 0.225 |
LIG_SH3_3 | 242 | 248 | PF00018 | 0.202 |
LIG_SH3_3 | 42 | 48 | PF00018 | 0.502 |
LIG_SUMO_SIM_par_1 | 66 | 72 | PF11976 | 0.548 |
LIG_TYR_ITIM | 87 | 92 | PF00017 | 0.483 |
LIG_TYR_ITIM | 96 | 101 | PF00017 | 0.439 |
LIG_UBA3_1 | 67 | 73 | PF00899 | 0.602 |
LIG_WRC_WIRS_1 | 177 | 182 | PF05994 | 0.249 |
MOD_CK1_1 | 161 | 167 | PF00069 | 0.414 |
MOD_CK1_1 | 256 | 262 | PF00069 | 0.312 |
MOD_CK1_1 | 54 | 60 | PF00069 | 0.612 |
MOD_CK2_1 | 66 | 72 | PF00069 | 0.461 |
MOD_GlcNHglycan | 125 | 128 | PF01048 | 0.587 |
MOD_GlcNHglycan | 196 | 199 | PF01048 | 0.455 |
MOD_GlcNHglycan | 53 | 56 | PF01048 | 0.383 |
MOD_GlcNHglycan | 6 | 9 | PF01048 | 0.342 |
MOD_GSK3_1 | 187 | 194 | PF00069 | 0.390 |
MOD_GSK3_1 | 221 | 228 | PF00069 | 0.321 |
MOD_GSK3_1 | 261 | 268 | PF00069 | 0.261 |
MOD_GSK3_1 | 54 | 61 | PF00069 | 0.621 |
MOD_N-GLC_1 | 21 | 26 | PF02516 | 0.304 |
MOD_NEK2_1 | 142 | 147 | PF00069 | 0.255 |
MOD_NEK2_1 | 193 | 198 | PF00069 | 0.225 |
MOD_NEK2_1 | 266 | 271 | PF00069 | 0.260 |
MOD_NEK2_2 | 97 | 102 | PF00069 | 0.455 |
MOD_PIKK_1 | 132 | 138 | PF00454 | 0.268 |
MOD_PIKK_1 | 74 | 80 | PF00454 | 0.588 |
MOD_PKA_2 | 118 | 124 | PF00069 | 0.257 |
MOD_PKA_2 | 225 | 231 | PF00069 | 0.261 |
MOD_PKA_2 | 39 | 45 | PF00069 | 0.489 |
MOD_Plk_1 | 21 | 27 | PF00069 | 0.520 |
MOD_Plk_4 | 118 | 124 | PF00069 | 0.257 |
MOD_Plk_4 | 151 | 157 | PF00069 | 0.471 |
MOD_Plk_4 | 253 | 259 | PF00069 | 0.229 |
MOD_Plk_4 | 266 | 272 | PF00069 | 0.214 |
MOD_Plk_4 | 82 | 88 | PF00069 | 0.612 |
MOD_ProDKin_1 | 187 | 193 | PF00069 | 0.373 |
MOD_SUMO_for_1 | 148 | 151 | PF00179 | 0.440 |
TRG_ENDOCYTIC_2 | 139 | 142 | PF00928 | 0.327 |
TRG_ENDOCYTIC_2 | 177 | 180 | PF00928 | 0.249 |
TRG_ENDOCYTIC_2 | 89 | 92 | PF00928 | 0.487 |
TRG_ENDOCYTIC_2 | 98 | 101 | PF00928 | 0.441 |
TRG_NLS_Bipartite_1 | 285 | 303 | PF00514 | 0.447 |
TRG_NLS_MonoExtC_3 | 284 | 289 | PF00514 | 0.509 |
TRG_NLS_MonoExtN_4 | 285 | 290 | PF00514 | 0.489 |
TRG_NLS_MonoExtN_4 | 296 | 303 | PF00514 | 0.441 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PF75 | Leptomonas seymouri | 74% | 100% |
A0A0S4IKY4 | Bodo saltans | 56% | 100% |
A0A1X0NYG0 | Trypanosomatidae | 60% | 100% |
A0A3Q8INK5 | Leishmania donovani | 89% | 100% |
A0A422NGL4 | Trypanosoma rangeli | 60% | 100% |
A4I1M5 | Leishmania infantum | 89% | 100% |
C9ZK67 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 63% | 100% |
E9AXQ9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
O94511 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 40% | 100% |
Q3SZ89 | Bos taurus | 34% | 85% |
Q3ZCD7 | Bos taurus | 39% | 100% |
Q4Q9R2 | Leishmania major | 90% | 99% |
Q55C17 | Dictyostelium discoideum | 36% | 100% |
Q5HYJ1 | Homo sapiens | 32% | 85% |
Q64232 | Rattus norvegicus | 39% | 100% |
Q68FF9 | Mus musculus | 22% | 100% |
Q8BFZ1 | Mus musculus | 34% | 86% |
Q99190 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 28% | 100% |
Q9CY27 | Mus musculus | 39% | 100% |
Q9M2U2 | Arabidopsis thaliana | 32% | 100% |
Q9N5Y2 | Caenorhabditis elegans | 42% | 100% |
Q9NZ01 | Homo sapiens | 39% | 100% |